Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects
Clinical trial NCT00529763 · COMPLETED
Trial details
- NCT number
- NCT00529763
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-17
- Primary completion
- 2009-06-17
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.